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As humans travel in space, they will interact with microbial flora from themselves, other crewmembers, 
their food, and the environment. While evaluations of microbial ecology aboard the Mir and ISS suggest a 
predominance of common environmental flora, the presence of (and potential for) infectious agents has 
been well documented. Likewise, pathogens have been detected during preflight monitoring of spaceflight 
food, resulting in the disqualification of that production lot from flight. These environmental and food 
organisms range from the obligate pathogen, Salmonella enterica serovar Typhimurium (S. 
Typhimurium), which has been responsible for disqualification and removal of food destined for ISS and 
has previously been reported from Shuttle crew refuse, to the opportunistic pathogen Staphylococcus 
aureus, isolated numerous times from ISS habitable compartments  and the crew.  Infectious disease 
events have affected spaceflight missions, including an upper respiratory infection that delayed the launch 
of STS-36 and an incapacitating Pseudomonas aeruginosa urinary tract infection of a crewmember during 
Apollo 13. These observations indicate that the crew has the potential to be exposed to obligate and 
opportunistic pathogens. This risk of exposure is expected to increase with longer mission durations and 
increased use of regenerative life support systems. As antibiotics are the primary countermeasure after 
infection, determining if their efficacy during spaceflight missions is comparable to terrestrial application 
is of critical importance. 
 
The NASA Rotating Wall Vessel (RWV) culture system has been successfully used as a spaceflight 
culture analogue to identify potential alterations in several key microbial characteristics, such as virulence 
and gene regulation, in response to spaceflight culture. We hypothesized that bacteria cultured in the low 
fluid shear RWV environment would demonstrate changes in efficacy of antibiotics compared to higher 
fluid shear controls. This study investigated the response of three medically significant microorganisms 
grown in the RWV to antibiotics that could be used on spaceflight missions. 
 
Our findings suggest potential alterations in antibiotic efficacy during spaceflight and indicate that future 
studies on the antibiotic response require additional basic research using the RWV and/or true spaceflight. 
However, while this analogue has reinforced these potential alterations, the results suggest the best 
approach for applied forward work is evaluating an in vivo system during spaceflight, including human 
and rodent studies. The complex nature of the analysis for many antibiotics and organism suggests the 
best approach to determine in vivo responses during pharmaceutical treatment is evaluating an in vivo 
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Background
• Examples of Spaceflight Experiments
– A Cytos 2 experiment aboard Salyut 7 
demonstrated increased resistance of S. aureus to 
oxacillin, chloramphenicol, and erythromycin and 
Escherichia coli to colistin and kanamycin (Tixador
1985).
– Juegensmeyer, et. al. observed both increased 
sensitivity and resistance by cultures of S. aureus, 
P. aeruginosa, Bacillus subtilis, and E. coli that had 
been re‐grown after having been on the MIR space 
station for 4 months (Juergensmeyer 1999).
– Spaceflight differentially regulates expression of 
genes encoding antibiotic efflux pumps in S.
Typhimurium, P. aeruginosa, and Candida albicans
(Wilson, 2007; Crabbé 2011; Crabbé 2013).
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Challenges for Translation to Operations 
• Microbial response to spaceflight may be altered 
by factors including:
– Medium chemical composition (Wilson, 2008)
– Growth substrate composition [agar v. liquid culture] 
(Kacena, 1999)
– Microbial strain variations
– Antibiotic mechanisms
– Phase of growth
– Single versus multispecies
• The design of any experiment may dramatically 
alter the question being answered
– Are we investigating the mass transfer of the antibiotic 
to the organism?
– Are we investigating the microbial responses to 
spaceflight culture that creates an alteration in the 
antibiotic resistance?
– Are we measuring microbial kill or measuring minimum 
inhibitory concentration (MIC)?
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Control Culture
Spaceflight Analogue 
Culture
Study Approach
• Employ the Rotating Wall Vessel (RWV) 
bioreactor as a spaceflight analogue to 
culture S. enterica serovar 
Typhimurium, P. aeruginosa, and S. 
aureus (methicillin resistant/MRSA) 
• Evaluate these organisms outside of 
the RWV with various concentrations of 
antibiotics that could be used during a 
spaceflight mission 
– Lethal Concentration, 50% kill [LC50]
• Challenges:
– Biofilm formation in stationary phase of 
P. aeruginosa and S. aureus
– Media choice
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Study Approach
Organism Antibiotic Mechanism
S. Typhimurium
Ceftriaxone Cephalosporin β‐lactam that interferes with cell wall synthesis
Azithromycin Azalide that interferes with protein synthesis
Levofloxacin Fluoroquinolone that inhibits bacterial DNA gyraseand topoisomerase IV
P. aeruginosa
Ceftriaxone Cephalosporin β‐lactam that interferes with cell wall synthesis
Azithromycin Azalide that interferes with protein synthesis
Levofloxacin Fluoroquinolone that inhibits bacterial DNA gyraseand topoisomerase IV
S. aureus
Amoxicillin β‐lactam that interferes with cell wall synthesis
Clindamycin Lincosamide that interfere with protein synthesis
Levofloxacin Fluoroquinolone that inhibits bacterial DNA gyraseand topoisomerase IV
6
Rotating Wall Vessel Bioreactor
• Rotating Wall Vessel (RWV)
– Solid body rotation in the reactor 
simulates several secondary effects 
of culture during spaceflight
– Correlation shown with virulence 
response, media composition 
impact, and molecular genetic 
impact of the Hfq global regulator 
(Wilson 2007; Wilson 2008) 
– Enables relatively high throughput 
– Capability to follow up spaceflight 
findings without the delays 
associated with true spaceflight 
experiments 
7
Operating positions of the bioreactors 
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Low-Fluid-Shear Orientation
(Low-Shear Modeled 
Microgravity: LSMMG)
Control Orientation
RWV studies with Staphylococcus aureus 
• S. aureus cultured 
to stationary 
phase in the RWV 
(20 hours) and 
challenged with 
25 µg/ml 
ciprofloxacin
• Increased 
resistance likely 
due to increased 
mucoidy of the S. 
aureus cultures
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Levels of antibiotic resistance for control and 
LSMMG cultured S. aureus N315 (*, P < 0.05) 
Castro, et. al. 2011
Overview of Findings
• Generally, the organisms did not display significant differences 
when compared to appropriate controls; however, a few interesting 
exceptions were noted. 
• S. Typhimurium exhibited alterations in antibiotic sensitivity to 
azithromycin, which interferes with protein synthesis, but only at 
one concentration when longer exposure times were adopted.
• Interestingly, P. aeruginosa displayed reproducible changes in 
resistance to azithromycin depending on the level of fluid shear, 
which was modulated through the incorporation of beads added to 
the RWV; suggesting a more complex shear associated mechanism 
with this antibiotic. 
• Methicillin resistant S. aureus (MRSA) strain N315 also 
demonstrated an enhanced resistance under microgravity‐analogue 
culture conditions to levofloxacin, a DNA gyrase inhibitor. 
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Conclusion
• Collectively, these findings reinforce previous spaceflight 
investigations suggesting potential alterations in antibiotic efficacy 
during spaceflight.
• As a high number of variables could impact the microbial response 
to antibiotics, future work using the RWV would be considered 
basic/mechanistic.
– Should be leveraged into Gap, AEH 14:  We need to determine how 
physical stimuli specific to the spaceflight environment, such as 
microgravity, induce unique changes in the dose‐response profiles of 
expected medically significant microorganisms.  
• The results also suggest the best approach for applied forward work 
in determining the impact on pharmaceutical use during spaceflight 
would be better served using a less reductionistic model, such an in 
vivo system (human or rodent) during spaceflight.
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